Combinostics is a healthcare technology company specializing in advanced diagnostic solutions for neurodegenerative diseases. The company focuses on leveraging artificial intelligence and machine learning to enhance the analysis of medical imaging and clinical data. Combinostics aims to improve the accuracy and efficiency of diagnoses, particularly in conditions such as Alzheimer's disease and other forms of dementia, by providing tools that support clinicians in making informed decisions. Their products are designed to facilitate early detection and personalized treatment plans, ultimately contributing to better patient outcomes.